
Discovery of nerve growth factor
1952 · discovery of a protein essential for nerve cell growth
For much of the twentieth century, researchers knew that nerve cells needed a suitable chemical environment to survive and to extend their long processes, the axons, toward their targets. An axon is the long fibre of a neuron that carries signals to other cells. What was missing was the substance that guided this growth. The question mattered because, during embryonic development, many neurons die if they fail to reach the right tissue, and understanding that process could shed light on disorders of the nervous system.
The work began with experimental embryology, the study of how tissues form in developing embryos. Rita Levi-Montalcini, an Italian neurologist, had been observing nerve growth in chick embryos. She later worked with the biochemist Stanley Cohen at Washington University in St. Louis, where extracts were prepared that strongly stimulated nerve growth. Sources date the discovery differently, but the reference point most often cited is 1952, when Levi-Montalcini and Hertha Meyer carried out the decisive preliminary work in Rio de Janeiro. Their 1954 publication provided the definitive proof that a specific protein was responsible for the effect.
The idea that a chemical could direct the growth of nerves was not easily accepted. Recognition came slowly, and the finding, together with the discovery of other related substances, was not widely acknowledged until 1986, when Levi-Montalcini and Cohen received the Nobel Prize in Physiology or Medicine. Since then the factor has been studied in detail. It is a protein made of two identical chains that acts as a local chemical messenger. Its active form binds to a receptor called TrkA on the surface of target cells and triggers internal pathways that favour cell survival. These include the PI3K/Akt and Ras/MAPK pathways, which switch on genes that produce anti-apoptotic proteins, molecules that protect a cell from programmed death.
The nerve growth factor gave its name to a wider family of neurotrophic factors, among them BDNF, neurotrophin-3 and ciliary neurotrophic factor. Beyond its role in development, its possible relevance to neurodegenerative diseases such as Alzheimer's has been investigated. However, the protein does not cross the blood-brain barrier, the barrier that shields the brain from substances in the blood, which limits its use within the central nervous system. Today the discovery is a landmark in neurobiology because it showed that the development of the nervous system depends on precise chemical signals and on competition between neurons for limited resources.
Key dates
- 1952 Preliminary work in Rio de Janeiro by Levi-Montalcini and Hertha Meyer, the usual starting point of the discovery.
- 1954 Publication that provided definitive proof that the protein existed.
- 1971 Determination of the primary structure of the factor, a step toward discovering its gene.
- 1986 Nobel Prize in Physiology or Medicine awarded to Levi-Montalcini and Cohen.
- 2012 The ovulation-inducing factor in semen is identified as beta-NGF, having previously been called OIF.
Key figures: Rita Levi-Montalcini; Stanley Cohen
Curiosities and anecdotes
A discovery in Brazil
Levi-Montalcini later recalled that the substance first hinted at its existence in St. Louis but revealed itself clearly in Rio de Janeiro, a city she compared to the lively atmosphere of its Carnival.
A factor present in semen
The factor is very abundant in seminal plasma and has been found to induce ovulation in some mammals, such as llamas. Its significance in humans remains unknown.
Sources
Original Medicapedia text based on:
Last updated: 5 November 2026 · How Medicapedia is made
A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.